Transdermal Delivery of Physostigmine: Effects of Enhancers and Pressure-Sensitive Adhesives
暂无分享,去创建一个
[1] Ju-Hyun Kim,et al. Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin. , 2000, International journal of pharmaceutics.
[2] Hoo-Kyun Choi,et al. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix , 1998 .
[3] C. Chiang,et al. Control of drug crystallization in transdermal matrix system , 1996 .
[4] J. Shah. Application of kinetic model to in vitro percutaneous permeation of drugs , 1996 .
[5] Bruno C. Hancock,et al. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. , 1995, Journal of pharmaceutical sciences.
[6] J. Jenner,et al. Transdermal Delivery of Physostigmine. A Pretreatment Against Organophosphate Poisoning , 1995, The Journal of pharmacy and pharmacology.
[7] T. Treves,et al. Transdermal Physostigmine in the Treatment of Alzheimer's Disease , 1994, Alzheimer disease and associated disorders.
[8] T. Kadar,et al. Transdermal penetration of physostigmine: Effects of oleic acid enhancer , 1993 .
[9] S. Cohen,et al. Kinetics of transdermal penetration of an organic ion pair: physostigmine salicylate. , 1992, Journal of pharmaceutical sciences.
[10] D. R. Anderson,et al. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. , 1991, Drug and chemical toxicology.
[11] Kokubo Takemasa,et al. Diffusion of drug in acrylic-type pressure-sensitive adhesive matrices. I. Influence of physical property of the matrices on the drug diffusion , 1991 .
[12] S. Cohen,et al. Partial molal volumes and solubilities of physostigmine in isopropanol:isopropyl myristate solvents in relation to skin penetrability. , 1991, Journal of pharmaceutical sciences.
[13] I. Ho,et al. Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[14] L. Harrell,et al. The effect of long‐term physostigmine administration in Alzheimer's disease , 1990, Neurology.
[15] S. Cohen,et al. Percutaneous absorption of physostigmine: optimization of delivery from a binary solvent by thermodynamic control. , 1990, Journal of pharmaceutical sciences.
[16] W. H. Carter,et al. Evaluation of a two-drug combination pretreatment against organophosphorus exposure. , 1990, Toxicology and applied pharmacology.
[17] Z. Liron,et al. Penetration of theophylline and adenosine into excised human skin from binary and ternary vehicles: effect of a nonionic surfactant. , 1989, Journal of pharmaceutical sciences.
[18] R. Mayeux,et al. Long‐term administration of oral physostigmine in Alzheimer's disease , 1988, Neurology.
[19] K. A. Walters,et al. Non‐ionic Surfactant Effects on Hairless Mouse Skin Permeability Characteristics , 1988, The Journal of pharmacy and pharmacology.
[20] A. Khalique,et al. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[21] P. Hartvig,et al. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients , 1986, Acta anaesthesiologica Scandinavica.
[22] K. A. Walters,et al. HYDRATION AND SURFACTANT EFFECTS ON METHYL NICOTINATE PENETRATION THROUGH HAIRLESS MOUSE SKIN , 1985 .
[23] G. Flynn,et al. Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum * , 1983, The Journal of pharmacy and pharmacology.
[24] K. Sugibayashi,et al. Interaction Between Drugs and Pressure-Sensitive Adhesives in Transdermal Therapeutic Systems , 2004, Pharmaceutical Research.
[25] J. Hadgraft,et al. Pharmaceutical skin penetration enhancement , 1993 .